Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biotechnology and Genetic Engineering Reviews is Scopus-indexed (Q2, CiteScore 6.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0264-8725Verify ISSN ↗2046-5556Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 116 / 325 | 64th | Q2 |
| Molecular Biology | 171 / 414 | 58th | Q2 |
| Bioengineering | 75 / 168 | 55th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–2024 (also 2012–2015, 2006–2010, 1996–2004, 1984–1994), best quartile Q2, CiteScore 6.3.
Biotechnology and Genetic Engineering Reviews is Q2 in Biotechnology (rank 116 of 325), Q2 in Molecular Biology (rank 171 of 414) and Q2 in Bioengineering (rank 75 of 168), by CiteScore 2025.
Biotechnology and Genetic Engineering Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.3, which places it in quartile Q2 at the 64th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.578, quartile Q2, with an H-index of 54.
Biotechnology and Genetic Engineering Reviews is published by Taylor and Francis Ltd. Its print ISSN is 0264-8725 and its online ISSN is 2046-5556.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biotechnology and Genetic Engineering Reviews has an h-index of 68 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 6.3, quartile Q2. On 2-year citations it ranks #289 of 309 Scopus journals in Biotechnology.
Biotechnology and Genetic Engineering Reviews published 284 papers in 2023. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023), authors are most often from China (88.8%), India (4.7%) and Saudi Arabia (1.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.